Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo test aims to spot hidden heart risk after attack

NCT ID NCT07268391

First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 24 times

Summary

This study looks at 95 people who had a severe heart attack to see if combining a special CT scan with a blood test for tiny molecules (miRNAs) can better predict long-term heart damage. The goal is to identify who is at high risk for heart failure so they can get closer monitoring and tailored treatment. Participants will have imaging and blood tests, but no new drugs or treatments are being tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centro Nacional de Investigaciones Cardiovasculares (CNIC)

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Complejo Asistencial Universitario de Salamanca

    Salamanca, Spain

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Clínico Universitario de Valencia

    Valencia, Spain

    Contact Email: •••••@•••••

  • Hospital La Princesa

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Ramón y Cajal

    Madrid, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.